Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve 1. To consider the appointment of Mr. Sumit Pawar as Chief Financial Officer of the Company.\r\n2. To consider the appointment of Mr. Yashvardhan Tupe as Additional Non-Executive Director of the Company.\r\n3. To consider the appointment of Mr. Sandip Sharma as Additional Non-Executive Independent Director of the Company.\r\n4. To take note of the circular resolution passed by the Company for the appointment of a statutory auditor of the Company.\r\n5. To consider and approve the date and Notice of the Extraordinary General Meeting of the Company.\r\n6. Other incidental Matters\r\n